Stock Ideas
New
Stocks
Funds
Screener
Sectors
Watchlists
More
BMRN - BioMarin Pharmaceutical Inc Stock Price, Fair Value and News
81.85
USD
-0.73
(-0.88%)
Market Closed
Watchlist
Share
Stock
/
BMRN
/
Insider-Transactions
Latest Insider Trading transactions for BMRN
CSV
Date
sorted ascending
Name
Buy/Sell
$ Value
# Shares
Avg. Price
Title
2024-05-03
Premium
sold (taxes)
Premium
Premium
Premium
EVP, Chief Technical Officer
2024-05-02
Premium
acquired
Premium
Premium
Premium
EVP, Chief Legal Officer
2024-05-02
Premium
sold
Premium
Premium
Premium
EVP, Chief Commercial Officer
2024-05-02
Premium
sold
Premium
Premium
Premium
EVP, Chief Legal Officer
2024-04-30
Premium
acquired
Premium
Premium
Premium
EVP, Chief Legal Officer
2024-04-30
Premium
acquired
Premium
Premium
Premium
EVP, Chief Technical Officer
2024-04-30
Premium
acquired
Premium
Premium
Premium
EVP, Chief Commercial Officer
2024-04-12
Premium
sold
Premium
Premium
Premium
-
2024-04-12
Premium
acquired
Premium
Premium
Premium
-
2024-04-11
Premium
acquired
Premium
Premium
Premium
-
2024-04-11
Premium
sold
Premium
Premium
Premium
-
2024-04-10
Premium
sold
Premium
Premium
Premium
GVP, Chief Accounting Officer
2024-03-28
Premium
sold
Premium
Premium
Premium
EVP, Chief Legal Officer
2024-03-18
Premium
acquired
Premium
Premium
Premium
-
2024-03-18
Premium
sold (taxes)
Premium
Premium
Premium
-
2024-03-18
Premium
sold (taxes)
Premium
Premium
Premium
GVP, Chief Accounting Officer
2024-03-15
Premium
acquired
Premium
Premium
Premium
EVP, Chief Technical Officer
2024-03-15
Premium
acquired
Premium
Premium
Premium
Chief Executive Officer
2024-03-15
Premium
acquired
Premium
Premium
Premium
EVP, Chief Financial Officer
2024-03-15
Premium
acquired
Premium
Premium
Premium
GVP, Chief Accounting Officer
2024-03-15
Premium
sold (taxes)
Premium
Premium
Premium
EVP, Chief Legal Officer
2024-03-15
Premium
sold (taxes)
Premium
Premium
Premium
-
2024-03-15
Premium
sold (taxes)
Premium
Premium
Premium
President, Worldwide R&D
2024-03-15
Premium
acquired
Premium
Premium
Premium
President, Worldwide R&D
2024-03-15
Premium
acquired
Premium
Premium
Premium
EVP, Chief Legal Officer
Rows per page:
10
25
50
All
1–25 of 50